Could a vaccine and antibody combo free people with HIV from daily pills?

NCT ID NCT07054931

Recruiting now Disease control Sponsor: University of Oxford Source: ClinicalTrials.gov ↗

First seen Nov 01, 2025 · Last updated May 22, 2026 · Updated 30 times

Summary

This study tests whether combining a vaccine that attacks HIV with a long-acting antibody can help people with HIV control the virus without daily antiretroviral therapy (ART). The trial involves 48 adults with well-controlled HIV. Participants will receive the vaccine and antibody, then briefly pause their regular medication to see if their immune system can keep the virus in check on its own.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HIV are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Centre for Clinical Vaccinology and Tropical Medicine (CCVTM)
RECRUITING

Oxford, OX3 7LJ, United Kingdom

Contact Phone: •••-•••-•••• Email: •••••@•••••
Guys and St Thomas' NHS Trust
RECRUITING

London, SE1 7EH, United Kingdom

Contact Phone: •••-•••-•••• Email: •••••@•••••
St Mary's Clinical Trial Unit
RECRUITING

London, W2 1NY, United Kingdom

Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

HIV